by danka | Jun 11, 2024 | Speakers Biosimilars LatAm - Europe 2024
Sandoz, Brazil Medical & Regulatory Affairs Director Cleber is the Medical & Regulatory Affairs Director at Sandoz Brazil. His previous roles include Medical Science Liaison (MSL), Medical Manager, Operations and Medical Excellence Manager, and Associate...
by danka | Jun 3, 2024 | Speakers Biosimilars LatAm - Europe 2024
mAbxience, Argentina Commercial Manager – LATAM Commercial manager for the LATAM region. Ten years of industry experience, specializing in the development of innovative molecules, with a keen interest in oncology. Background in molecular biology and business...
by danka | May 18, 2024 | Speakers Biosimilars LatAm - Europe 2024
ALAFARPE, Peru Executive Director Executive Director at ALAFARPE, Economist from Universidad del Pacífico, Lima, Peru. Master in International Economy at Yale University, and Candidate of MSc in Health Economics, Policy and Management at LSE. With wide experience...
by danka | Apr 30, 2024 | Speakers Biosimilars LatAm - Europe 2024
BioSim, Spain Deputy Director Dr. Isabel del Río Álvarez holds a master’s degree in Pharmacoeconomics from the University Carlos III of Madrid (Spain) and a PhD in Biotechnology, specialising in plant-microbe molecular interactions, from the Polytechnic...
by danka | Apr 29, 2024 | Speakers Biosimilars LatAm - Europe 2024
Bio-Sourcing, Belgium SMO Francois-Xavier Frapaise (Xavier) holds a MD from the University of Paris and has over 40 years’ experience in the Pharma Industry (Sanofi, Abbott, Bayer, Merck, Grünenthal as well as in several start-ups) in different roles such as Board...
by danka | Apr 10, 2024 | Speakers Biosimilars LatAm - Brazil 2024, Speakers Biosimilars LatAm - Europe 2024
Blau Farmacêutica, Brazil RD&I Director Uilberson, is in charge of R&D area at Blau Farmacêutica in Brazil, leads the development of biosimilars for the Brazilian market and other Latin American countries. Its strategic scientific, regulatory and clinical...
